Replies to post #287655 on Amarin Corp Plc (AMRN)

[Bouf]

HK—your compliant is with Congress, not so much with the Courts. The HW Act gives generics the ability to challenge patents in this way, presumably on the basis that this helps to improve affordability of drugs in the US. This process will not change unless the HW act is changed.

B